Department of Gynecology, Breast Unit, University of Genoa, 10 Largo Rosanna Benzi, Genoa, Italy.
Arch Gynecol Obstet. 2010 Apr;281(4):769-73. doi: 10.1007/s00404-009-1264-0. Epub 2009 Oct 30.
Metastatic breast cancer is rare in the female genital tract, and when present it more commonly tends to involve ovary or endometrium; uterine cervix is only occasionally involved. This condition poses differential diagnostic problems in the settings of clinical and pathological investigations.
An asymptomatic 78-year-old woman came to our attention in the context of routine gynecological surveillance; clinical examination disclosed enlarged uterine body and cervix. Our patient then underwent computed tomography and magnetic resonance imaging that outlined the possibility of cervical cancer with parametrial involvement. Moreover, a suspect mass was found on the mammogram in the left breast. Breast surgical excision was performed, which revealed invasive breast carcinoma, while synchronous cervical biopsy discovered distant metastasis in the uterine cervix. On histological examination, both lesions showed non-cohesive architectural pattern consistent with lobular morphology; anyway, to rule out primary poorly differentiated cervical cancer, appropriate immunohistochemical panel was performed, which confirmed the mammary derivation of the tumor. Due to disseminate disease, the patient underwent multisystemic medical treatment including radiotherapy, chemotherapy and hormone therapy, and she is still alive at 30-month follow-up.
Genital tract metastases in patients with known breast carcinoma can present with abnormal vaginal bleeding, but they often are asymptomatic. Therefore, only strict gynecological surveillance of these patients can permit early detection of these secondary lesions. Aggressive treatment of isolated cervical metastasis should be performed when feasible; otherwise, systemic chemotherapy with taxane could be sufficient in increasing survival. It should be emphasized that, in most cases, only accurate immunohistochemical investigation, particularly if performed on the primary lesion as well, can solve differential diagnostic problems and allow the clinician to establish appropriate treatment.
转移性乳腺癌在女性生殖道中较为罕见,当发生时,更常累及卵巢或子宫内膜;子宫颈仅偶尔受累。这种情况在临床和病理检查中会产生鉴别诊断问题。
一名无症状的 78 岁女性因常规妇科监测来我院就诊;临床检查显示子宫体和子宫颈增大。随后患者进行了计算机断层扫描和磁共振成像,提示可能存在宫颈癌伴宫旁受累。此外,乳房 X 线照相检查发现左侧乳房有可疑肿块。进行了乳房切除术,结果显示为浸润性乳腺癌,而同期的宫颈活检发现子宫颈有远处转移。组织学检查显示,两个病变均表现出非黏附性结构模式,符合乳腺小叶形态;然而,为了排除原发性低分化宫颈癌,进行了适当的免疫组织化学检测,证实了肿瘤的乳腺来源。由于疾病播散,患者接受了包括放疗、化疗和激素治疗在内的多系统治疗,截至 30 个月随访时仍存活。
已知患有乳腺癌的患者的生殖道转移可能表现为异常阴道出血,但通常无症状。因此,只有对这些患者进行严格的妇科监测,才能早期发现这些继发性病变。可行时应积极治疗孤立性宫颈转移;否则,全身化疗加紫杉类药物可能足以提高生存率。应强调的是,在大多数情况下,只有准确的免疫组织化学检查,特别是对原发性病变进行检查,才能解决鉴别诊断问题,并使临床医生能够确定适当的治疗方案。